Juniper is a venture capital fund explicitly focused on accelerating the Bioindustrial Revolution by investing in engineered biology applications for manufacturing, mining, food, and conservation rather than traditional healthcare biotech. The fund targets first checks into category-creating companies at the earliest stage where AI, robotics, and engineered biology collide, combining deep synthetic biology expertise with climate policy and founder experience to back synthetic biology's boldest climate moonshots.